| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/24/2013 | CN103221404A Nitrogen heterocyclic compounds useful as PDE10 inhibitors |
| 07/24/2013 | CN103221402A Triazole derivatives and their use for neurological disorders |
| 07/24/2013 | CN103221392A Bridged spiro[2.4]heptane ester derivatives |
| 07/24/2013 | CN103221049A Aprepitant l-proline composition and cocrystal |
| 07/24/2013 | CN103221046A Piperidinyl-substituted lactams as gpr119 modulators |
| 07/24/2013 | CN103214473A Dibenzo[b,f][1,4]oxazapine compounds |
| 07/24/2013 | CN103214460A Chemical compounds |
| 07/24/2013 | CN103214456A Benzimidazole compound with antitumour activity as well as preparation method and application thereof |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN102250117B Dibenzoxazine containing oxazole ring and preparation method thereof |
| 07/24/2013 | CN102112439B 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 07/24/2013 | CN101861314B 1-hydroxyl-2- naphthoate of N4-[(2, 2-difluoro-4N-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-N2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine |
| 07/24/2013 | CN101258131B 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | US8492415 Azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) in antiviral therapy (HIV) |
| 07/23/2013 | US8492387 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/23/2013 | US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists |
| 07/23/2013 | US8492311 Isoxazoline-substituted benzamide compound and pesticide |
| 07/23/2013 | US8492111 Arylalkylamine compound and process for preparing the same |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/23/2013 | CA2545261C Piperidine-substituted indoles- or heteroderivatives thereof |
| 07/18/2013 | WO2013106646A2 Compounds and methods for the inhibition of vcb e3 ubiquitin ligase |
| 07/18/2013 | WO2013106643A2 Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase |
| 07/18/2013 | WO2013106614A1 Triazolyl-substituted pyridyl compounds useful as kinase inhibitors |
| 07/18/2013 | WO2013106612A1 Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors |
| 07/18/2013 | WO2013106409A1 Benzamide derivatives as modulators of the follicle stimulating hormone |
| 07/18/2013 | WO2013105676A1 Benzimidazole derivatives as mch receptor antagonists |
| 07/18/2013 | WO2013105100A1 Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide and intermediates thereof |
| 07/18/2013 | WO2013104705A1 Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides |
| 07/18/2013 | WO2013104591A1 Heterocyclic derivatives as trace amine associated receptors (taars) |
| 07/18/2013 | WO2013104342A1 Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013070116A3 Novel antithrombotic and antiatherosclerotic agent and method for producing same (variants) |
| 07/18/2013 | WO2013048949A3 Selective nr2b antagonists |
| 07/18/2013 | WO2012074869A8 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture |
| 07/18/2013 | US20130184468 Process for the preparation of propionic acid derivatives |
| 07/18/2013 | US20130184467 Process and composition of making polymerizable resins containing oxazolidone |
| 07/18/2013 | US20130184457 Method for the preparation of rivoraxaban |
| 07/18/2013 | US20130184309 Metalloenzyme inhibitor compounds |
| 07/18/2013 | US20130184301 Methods of Treating Post-Traumatic Stress Disorder Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184300 Methods of Treating Traumatic Brain Injury Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184292 Processes for Making Compounds Useful as Inhibitors of ATR Kinase |
| 07/18/2013 | US20130184284 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184277 Adamantyl diamide derivatives and uses of same |
| 07/18/2013 | US20130184275 Hydrazone modulators of cannabinoid receptors |
| 07/18/2013 | US20130184271 Methods for Treating Parkinson's Disease Using Pro-Neurogenic Compounds |
| 07/18/2013 | US20130184262 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184261 Pyridazinone derivatives |
| 07/18/2013 | US20130184260 Pyridazinone derivatives |
| 07/18/2013 | US20130184259 Pyridones useful as inhibitors of kinases |
| 07/18/2013 | US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 07/18/2013 | US20130184257 Piperidinyl-substituted lactams as gpr119 modulators |
| 07/18/2013 | US20130184256 New substituted glycinamides, process for their manufacture and use thereof as medicaments |
| 07/18/2013 | US20130184255 Fused heterocyclic compounds as ion channel modulators |
| 07/18/2013 | US20130184251 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
| 07/18/2013 | US20130184241 Naphthalene Derivative |
| 07/18/2013 | US20130184155 Herbicidal Benzoxazinones |
| 07/18/2013 | CA2860808A1 Benzamide derivatives as modulators of the follicle stimulating hormone |
| 07/18/2013 | CA2856204A1 Heterocyclic derivatives as trace amine associated receptors (taars) |
| 07/17/2013 | EP2615087A2 Phenylalanine derivatives |
| 07/17/2013 | EP2615086A1 2,4-Diaminoquinazolines for the treatment of spinal muscular atrophy |
| 07/17/2013 | EP2615085A1 Pyridyl derivatives as CFTR modulators |
| 07/17/2013 | EP2615084A1 Prostaglandin d synthase inhibitory piperidine compounds |
| 07/17/2013 | EP2614824A1 Therapeutic agent for pain |
| 07/17/2013 | EP2614058A1 Polymorphs and salts of n- [5- [4- (5- { [(2r,6s) -2, 6 - dimethyl - 4 -morpholinyl]methyl} - 1, 3 - oxazol - 2 - yl) - 1h- inda zol-6-yl]-2- (methyloxy) - 3 - pyridinyl]methanesulfonamide |
| 07/17/2013 | EP2614052A1 Novel piperazine analogs as broad-spectrum influenza antivirals |
| 07/17/2013 | EP2613787A2 Processes for the preparation of 4-{4-[5(s)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl} morpholin-3-one |
| 07/17/2013 | EP2613785A1 Heteroarylmethyl amides |
| 07/17/2013 | EP2613782A2 Indazole derivatives useful as erk inhibitors |
| 07/17/2013 | CN103209980A Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy |
| 07/17/2013 | CN103209979A Therapeutic agents 976 |
| 07/17/2013 | CN103209977A Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals |
| 07/17/2013 | CN103209975A Substituted bipyridines for use in organic light-emitting devices |
| 07/17/2013 | CN103209963A 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds |
| 07/17/2013 | CN103209962A Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| 07/17/2013 | CN103209960A Sulfonamide compounds useful as CYP17 inhibitors |
| 07/17/2013 | CN103204834A Aliskiren intermediate, and preparation method and application thereof |
| 07/17/2013 | CN102186477B Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| 07/17/2013 | CN102083820B Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 07/17/2013 | CN102066345B Oxazolidine derivatives as NMDA antagonists |
| 07/17/2013 | CN101932577B Heteroaryl-substituted piperidines |
| 07/17/2013 | CN101687857B Pyridazinone derivates |
| 07/17/2013 | CN101641339B Compounds for the prevention and treatment of cardiovascular diseases |
| 07/17/2013 | CN101528225B 2-aminobenzoxazole carboxamides as 5HT3 modulators |
| 07/17/2013 | CN101490036B Factor xa inhibitors |
| 07/17/2013 | CN101479008B Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower HDL-C and lower cholesterol |
| 07/17/2013 | CN101415683B New compounds |
| 07/17/2013 | CN101374815B Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
| 07/17/2013 | CN101203495B Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET |
| 07/16/2013 | US8487111 Substituted oxazolidinones and their use |
| 07/16/2013 | US8487106 Process for preparation of 2-methyl-2′-phenylpropionic acid derivatives and novel intermediate compounds |
| 07/16/2013 | US8487095 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
| 07/16/2013 | US8487094 Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
| 07/16/2013 | US8486982 1,2,4-oxadiazole benzoic acids |
| 07/16/2013 | US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders |
| 07/16/2013 | US8486952 Compounds for the reduction of β-amyloid production |
| 07/16/2013 | US8486941 Phenyl amino pyrimidine compounds and uses thereof |
| 07/16/2013 | US8486939 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 07/16/2013 | US8486934 Oxadiazine-substituted arylamides |